Table 3 Methylation status of NMDAR2B and clinicopathologic factors in clinical NSCLCs
From: Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma
Cases (N = 216) | Methylation (N = 131, 61%) | |
|---|---|---|
Gender | Male (152) | 93 (61) * |
| Â | Female (64) | 38 (59) |
Age** | < 65 (107) | 62 (58) |
|  | ≥ 65 (109) | 69 (63) |
Smoking | Never (64) | 36 (56) |
| Â | Smoker (152) | 95 (63) |
Histology | Adenocarcinoma (126) | 68 (54) |
| Â | Others*** (90) | 63 (70) |
T factor | T1 (135) | 81 (60) |
| Â | T2, 3, 4 (81) | 50 (62) |
N factor | N0 (115) | 73 (63) |
| Â | N1, 2, 3 (101) | 58 (57) |
Stage | I (80) | 48 (60) |
| Â | II, III, IV (136) | 83 (61) |